REAL WORLD EVIDENCE NEEDS IN ONCOLOGY:
White Paper based on new trial results from ESMO Congress, 20-24 October 2023, Madrid.
NSCLC’s complex nature, characterized by diverse pathological profiles and variable responses to treatments, underscores the need for ongoing research and innovation in treatment strategies.
OXON has analyzed the results of the studies presented at ESMO 2023, and in this white paper summarizes the latest developments offering a comprehensive view of the latest strategies and outcomes in NSCLC management. The goal is to bridge research with clinical practice, demonstrating how these insights could reshape treatment guidelines for NSCLC.
To download the white paper please complete the following form: